[go: up one dir, main page]

PE20070071A1 - PIRAZOLO [1,5-a]PIRIMIDINAS HALOGENADAS Y METODOS DE PREPARACION - Google Patents

PIRAZOLO [1,5-a]PIRIMIDINAS HALOGENADAS Y METODOS DE PREPARACION

Info

Publication number
PE20070071A1
PE20070071A1 PE2006000684A PE2006000684A PE20070071A1 PE 20070071 A1 PE20070071 A1 PE 20070071A1 PE 2006000684 A PE2006000684 A PE 2006000684A PE 2006000684 A PE2006000684 A PE 2006000684A PE 20070071 A1 PE20070071 A1 PE 20070071A1
Authority
PE
Peru
Prior art keywords
pyrimidin
thiophene
carbonyl
phenyl
alkyl
Prior art date
Application number
PE2006000684A
Other languages
English (en)
Inventor
Burniol Luis Anglada
Benet Albert Palomer
Antonio Guglieta
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of PE20070071A1 publication Critical patent/PE20070071A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

REFERIDA A DERIVADOS DE PIRIMIDINA DE FORMULA (I), DONDE R ES ALQUILO C1-C6; R1 ES ALQUILO C1-C6 O ALQUINILO C1-C6; X ES UN ATOMO DE HALOGENO, DE PREFERENCIA FLUOR O CLORO; Y ES CO Y SO2. SON COMPUESTOS PREFERIDOS: N-{2-FLUORO-5-[3-(TIOFENO-2-CARBONIL)-PIRAZOLO[1,5-a]PIRIMIDIN-7-IL]-FENIL}-N-METIL-ACETAMIDA, N-{2-CLORO-5-[3-(TIOFENO-2-CARBONIL)-PIRAZOLO[1,5-a]PIRIMIDIN-7-IL]-FENIL}-N-METIL-ACETAMIDA, N-{2-FLUORO-5-[3-(TIOFENO-2-CARBONIL)-PIRAZOLO[1,5-a]PIRIMIDIN-7-IL]-FENIL}-N-METIL-METANOSULFONAMIDA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS TIENEN AFINIDAD POR EL RECEPTOR GABA A Y SON UTILES EN EL TRATAMIENTO DE LA ANSIEDAD, EPILEPSIA, TRASTORNOS DEL SUENO, ENTRE OTROS
PE2006000684A 2005-06-21 2006-06-19 PIRAZOLO [1,5-a]PIRIMIDINAS HALOGENADAS Y METODOS DE PREPARACION PE20070071A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69286605P 2005-06-21 2005-06-21
EP05105478A EP1736475A1 (en) 2005-06-21 2005-06-21 Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates

Publications (1)

Publication Number Publication Date
PE20070071A1 true PE20070071A1 (es) 2007-02-01

Family

ID=35311853

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000684A PE20070071A1 (es) 2005-06-21 2006-06-19 PIRAZOLO [1,5-a]PIRIMIDINAS HALOGENADAS Y METODOS DE PREPARACION

Country Status (24)

Country Link
US (3) US8530482B2 (es)
EP (2) EP1736475A1 (es)
JP (1) JP5010591B2 (es)
KR (1) KR101465802B1 (es)
CN (1) CN101243089B (es)
AR (1) AR054785A1 (es)
AT (1) ATE467635T1 (es)
AU (1) AU2006261025B2 (es)
BR (1) BRPI0612075A2 (es)
CA (1) CA2612726C (es)
CY (1) CY1111452T1 (es)
DE (1) DE602006014272D1 (es)
DK (1) DK1899343T3 (es)
ES (1) ES2345999T3 (es)
MX (1) MX2007016340A (es)
NO (1) NO339973B1 (es)
PE (1) PE20070071A1 (es)
PL (1) PL1899343T3 (es)
PT (1) PT1899343E (es)
RU (1) RU2478101C2 (es)
SI (1) SI1899343T1 (es)
TW (1) TWI382985B (es)
UY (1) UY29618A1 (es)
WO (1) WO2006136530A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1736475A1 (en) * 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates
MX2008011853A (es) * 2006-03-17 2008-09-29 Wyeth Corp Derivados de pirazolo[1,5-a]pirimidina y sus metodos de uso.
EP1884516A1 (en) * 2006-08-04 2008-02-06 Ferrer Internacional, S.A. Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions
EP1918290A1 (en) 2006-10-11 2008-05-07 Ferrer Internacional, S.A. Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
EP1956021A1 (en) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
EP1921079A1 (en) * 2006-11-08 2008-05-14 Ferrer Internacional, S.A. Amorphous form of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
AU2010205739B2 (en) 2009-01-13 2015-12-10 Interquim S.A. Process for the preparation of N-[5-(3-dimethylamino-acryloyl)-2-fluoro-phenyl]-N-methyl-acetamide
WO2014163162A1 (ja) 2013-04-04 2014-10-09 武田薬品工業株式会社 複素環化合物
JP2018199623A (ja) * 2015-10-22 2018-12-20 大正製薬株式会社 含窒素縮合複素環化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521422A (en) * 1983-06-23 1985-06-04 American Cyanamid Company Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
WO2002072585A2 (de) * 2001-03-14 2002-09-19 Grünenthal GmbH Substituierte pyrazolo- und thiazolopyrimidine als analgetika
JP2005516955A (ja) * 2001-12-21 2005-06-09 バイエル・ヘルスケア・アクチェンゲゼルシャフト アロイル・ピリジノン化合物
ES2222813B1 (es) * 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
WO2006033795A2 (en) * 2004-09-17 2006-03-30 Wyeth Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth
WO2006033796A1 (en) * 2004-09-17 2006-03-30 Wyeth SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AND PROCESS FOR MAKING SAME
CN100528875C (zh) * 2005-02-18 2009-08-19 美德（江西）生物科技有限公司 无结晶型态的印地普隆及其制备方法
EP1736475A1 (en) * 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates

Also Published As

Publication number Publication date
MX2007016340A (es) 2008-03-10
RU2008101371A (ru) 2009-07-27
UY29618A1 (es) 2006-10-31
WO2006136530A1 (en) 2006-12-28
CY1111452T1 (el) 2015-08-05
US20130331401A1 (en) 2013-12-12
AR054785A1 (es) 2007-07-18
NO339973B1 (no) 2017-02-27
JP5010591B2 (ja) 2012-08-29
CA2612726A1 (en) 2006-12-28
DE602006014272D1 (de) 2010-06-24
AU2006261025A1 (en) 2006-12-28
TWI382985B (zh) 2013-01-21
PL1899343T3 (pl) 2010-10-29
JP2008543913A (ja) 2008-12-04
US20090111848A1 (en) 2009-04-30
CN101243089B (zh) 2011-07-06
US10072000B2 (en) 2018-09-11
DK1899343T3 (da) 2010-09-06
KR101465802B1 (ko) 2014-11-27
EP1899343A1 (en) 2008-03-19
CA2612726C (en) 2013-10-01
TW200726769A (en) 2007-07-16
SI1899343T1 (sl) 2010-09-30
ATE467635T1 (de) 2010-05-15
CN101243089A (zh) 2008-08-13
RU2478101C2 (ru) 2013-03-27
KR20080032104A (ko) 2008-04-14
US20130331610A1 (en) 2013-12-12
HK1116184A1 (en) 2008-12-19
US8530482B2 (en) 2013-09-10
BRPI0612075A2 (pt) 2010-10-19
AU2006261025B2 (en) 2011-09-08
ES2345999T3 (es) 2010-10-07
EP1899343B1 (en) 2010-05-12
EP1736475A1 (en) 2006-12-27
PT1899343E (pt) 2010-08-17
US20160368912A9 (en) 2016-12-22
NO20080393L (no) 2008-03-10

Similar Documents

Publication Publication Date Title
FIC20210022I1 (fi) tukatinibi, valinnaisesti farmaseuttisesti hyväksyttävän suolan tai solvaatin muodossa
PE20081800A1 (es) NUEVOS DERIVADOS DE 3-([1,2,4]TRIAZOLO[4,3-a]PIRIDIN-7-IL)BENZAMIDA
NO20054208L (no) Nitrogen-substituerte heksahydropyrazino[1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter
NO20054085L (no) Substituerte heksahydropyrazino [1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter
DK1723144T3 (da) Yderligere heteropolycykliske forbindelser og anvendelse deraf som metabotropiske glutamareceptor-antagonister
MXPA06012640A (es) Compuestos de morfolina.
DK1869049T3 (da) Imidazopyridazinforbindelser
PE20070071A1 (es) PIRAZOLO [1,5-a]PIRIMIDINAS HALOGENADAS Y METODOS DE PREPARACION
TNSN08478A1 (en) Pyrazolo [3,4-d] pyrimidine derivatives useful to treat respiratory disorders
DK1553953T3 (da) Fremgangsmåde og præparat omfattende latanoprost til behandling af okulær hypertension og glaucom
UA100132C2 (en) Isoxazolo-pyridine derivatives
PE20120575A1 (es) Derivados de pirazolopirimidina como inhibidores de jak quinasas
ZA200710379B (en) Pyrrolopyridines useful as inhibitors of protein kinase
NO20074431L (no) Pyrrolopyrimidiner nyttige som proteinkinaseinhibitorer
WO2007038209A3 (en) Fused tetracyclic mglur1 antagonists as therapeutic agents
PE20081581A1 (es) COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
DE602004018630D1 (en) Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten
MXPA05013733A (es) 2-aminobenzotiazoles como agonistas inversos del receptor de cb1.
WO2009038757A3 (en) Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
ATE455756T1 (de) Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung
PE20060736A1 (es) DERIVADOS DE PIRROL COMO ANTAGONISTAS DE CRTh2
MX2007012438A (es) Forma cristalina de un compuesto de quinolinona-carboxamida.
DE602005002653D1 (de) Stabilisierte zusammensetzungen mit einem therapeutischen wirkstoff; zitronensäure oder einer konjugierten base und chlordioxid
WO2007070393A3 (en) Mglur1 anatgonists as therapeutic agents
NO20072972L (no) Terapeutiske pyrazolo[3,4-B]pyridiner og indazoler

Legal Events

Date Code Title Description
FG Grant, registration